Tango Therapeutics President, R&D Adam Crystal Sells $125K of Stock
Adam Crystal, President, R&D, sold 5,000 shares of Tango Therapeutics, Inc. at $25.00 a share, worth $125K in total on Nov 11, 2026. Shares held after the trade: 115,743 (-4.1%).
Tango Therapeutics President, R&D Adam Crystal Sells $112K of Stock
Adam Crystal, President, R&D, sold 5,000 shares of Tango Therapeutics, Inc. at $22.26 to $22.99 a share (average $22.42) in 2 transactions, worth $112K in total on Nov 2, 2026. Shares held after the trade: 115,743 (-0.9%).
Tango Therapeutics Principal Accounting Officer Jessica Newcomb Sells $158K of Stock
Jessica Newcomb, Principal Accounting Officer, sold 7,031 shares of Tango Therapeutics, Inc. at $22.28 to $22.98 a share (average $22.42) in 2 transactions, worth $158K in total on Nov 2, 2026. Shares held after the trade: 52,090 (-2.7%).
Tango Therapeutics President, R&D Adam Crystal Sells $661K of Stock
Adam Crystal, President, R&D, sold 27,000 shares of Tango Therapeutics, Inc. at $24.45 to $25.32 a share (average $24.47) in 2 transactions, worth $661K in total on Oct 1, 2026. Shares held after the trade: 115,743 (-0.5%).
Tango Therapeutics Principal Accounting Officer Jessica Newcomb Sells $199K of Stock
Jessica Newcomb, Principal Accounting Officer, sold 8,200 shares of Tango Therapeutics, Inc. at $22.80 to $25.17 a share (average $24.22) in 3 transactions, worth $199K in total on Sep 22, 2026. Shares held after the trade: 59,121 (-3.9%).